Evaluation of Glypican-3 expression in benign and malignant salivary gland tumors

Introduction: Glypican-3 (GPC3) is involved in regulation of cell proliferation and morphogenesis. It is abundant in embryonic tissue, but limited in most adult tissues. GPC3 deletion or mutation can disturb the balance between cell apoptosis and proliferation, which may result in tumorigenesis. Thi...

Full description

Saved in:
Bibliographic Details
Main Authors: Azadeh Andisheh-Tadbir (Author), Mohammad Javad Ashraf (Author), Ali Goodarzi (Author), Razieh Zare (Author)
Format: Book
Published: Elsevier, 2019-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e4b7949cace24f7abfddfeb9e7e15da2
042 |a dc 
100 1 0 |a Azadeh Andisheh-Tadbir  |e author 
700 1 0 |a Mohammad Javad Ashraf  |e author 
700 1 0 |a Ali Goodarzi  |e author 
700 1 0 |a Razieh Zare  |e author 
245 0 0 |a Evaluation of Glypican-3 expression in benign and malignant salivary gland tumors 
260 |b Elsevier,   |c 2019-01-01T00:00:00Z. 
500 |a 2212-4268 
500 |a 10.1016/j.jobcr.2018.09.002 
520 |a Introduction: Glypican-3 (GPC3) is involved in regulation of cell proliferation and morphogenesis. It is abundant in embryonic tissue, but limited in most adult tissues. GPC3 deletion or mutation can disturb the balance between cell apoptosis and proliferation, which may result in tumorigenesis. This study aimed to investigate the GPC3 expression in salivary gland tumors (SGTs) and the adjacent non-neoplastic tissues. Methods: This study reviewed 50 samples of salivary tumors from the archive of Khalili Hospital, Shiraz, Iran, including 17 cases of pleomorphic adenoma (PA), 16 cases of mucoepidermoid carcinoma (MEC), and 17 cases of adenoid cystic carcinoma (ACC); as well as a control group of 23 cases of normal salivary gland tissues. GPC3 expression was investigated through immunohistochemistry. Results: GPC3 expression was significantly higher in malignant tumors (MEC and ACC) than in PA, and higher in PA than in the normal salivary glands (P < 0.001). The expression intensity was moderate to strong in malignant tumors and weak to moderate in benign tumors. No strong positivity was observed in normal salivary gland tissues (P < 0.001). Nor was any association detected between the GPC3 expression and intensity with the clinicopathologic parameters. Conclusion: Although GPC3 overexpression was observed at the protein level in SGTs, and its expression was not related with the clinicopathologic factors, the potential use of GPC3 for diagnostic, therapeutic, and prognostic purposes requires further investigations. 
546 |a EN 
690 |a Salivary gland tumor 
690 |a PA 
690 |a ACC 
690 |a MEC 
690 |a GPC3 
690 |a Dentistry 
690 |a RK1-715 
655 7 |a article  |2 local 
786 0 |n Journal of Oral Biology and Craniofacial Research, Vol 9, Iss 1, Pp 63-66 (2019) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2212426817302919 
787 0 |n https://doaj.org/toc/2212-4268 
856 4 1 |u https://doaj.org/article/e4b7949cace24f7abfddfeb9e7e15da2  |z Connect to this object online.